Page last updated: 2024-09-05

nbi 27914 and lauric acid

nbi 27914 has been researched along with lauric acid in 1 studies

Compound Research Comparison

Studies
(nbi 27914)
Trials
(nbi 27914)
Recent Studies (post-2010)
(nbi 27914)
Studies
(lauric acid)
Trials
(lauric acid)
Recent Studies (post-2010) (lauric acid)
7602992138343

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, J; Fu, H; Guan, X; Gui, B; Guo, Y; Hu, J; Jin, L; Li, S; Wang, J; Xu, Y; Zhang, Q; Zhang, R1

Other Studies

1 other study(ies) available for nbi 27914 and lauric acid

ArticleYear
Urocortin promotes the development of vasculitis in a rat model of thromboangiitis obliterans via corticotrophin-releasing factor type 1 receptors.
    British journal of pharmacology, 2009, Volume: 157, Issue:8

    Topics: Aniline Compounds; Animals; Arteritis; Blood Coagulation; Corticotropin-Releasing Hormone; Cyclooxygenase 2; Dinoprostone; Intercellular Adhesion Molecule-1; Lauric Acids; Male; Peptide Fragments; Pyrimidines; Rats; Rats, Wistar; Receptors, Corticotropin-Releasing Hormone; Thromboangiitis Obliterans; Thromboxane B2; Urocortins

2009